ASF Research Grants
ASF Research Grants from the Angelman Syndrome Foundation fund innovative, translational research to advance scientific understanding and treatment of Angelman syndrome.
Funder: Angelman Syndrome Foundation
Due Dates: August 15, 2026 (proposal submission deadline) | September 1, 2026 (annual/full proposal deadline)
Funding Amounts: Up to $100,000 per year; 1- or 2-year grants; indirect costs capped at 10% within total budget.
Summary: Supports innovative, translational research to advance understanding and treatment of Angelman syndrome, emphasizing global collaboration and real-world impact.
Description
The Angelman Syndrome Foundation (ASF) Research Grants program funds pioneering projects that advance the science, care, and therapeutic development for Angelman syndrome (AS). The program invites proposals from researchers and clinicians worldwide, seeking innovative studies that align with ASF's Research Roadmap. Priority is given to translational and collaborative projects that target breakthroughs in UBE3A gene regulation, novel therapeutic strategies (including gene therapy, small molecule therapeutics, and preclinical models), clinical care advancements, and the development of objective clinical endpoints and biomarkers. ASF's goal is to accelerate progress from discovery to tangible improvements in the lives of individuals with AS.
